Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells.
Cell Biochem Biophys. 2022 Dec;80(4):681-687. doi: 10.1007/s12013-022-01094-0. Epub 2022 Oct 1.
Cell Biochem Biophys. 2022.
PMID: 36181622
Analysis of serum lipid parameters predicting lipid metabolic disorders in TSC-AML patients with treatment of mTOR inhibitors.
Wang W, Wang Z, Zhao Y, Wang X, Li H, Zhang Y.
Wang W, et al.
J Clin Pharm Ther. 2022 Jul;47(7):979-985. doi: 10.1111/jcpt.13631. Epub 2022 Mar 1.
J Clin Pharm Ther. 2022.
PMID: 35229896
Item in Clipboard
CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex.
Wang W, Guo H, Shi B, Sun H, Li H, Zhang Y, Cai Y.
Wang W, et al.
Int Urol Nephrol. 2019 Apr;51(4):671-676. doi: 10.1007/s11255-019-02093-6. Epub 2019 Feb 11.
Int Urol Nephrol. 2019.
PMID: 30756282
Item in Clipboard
Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.
Cai Y, Guo H, Wang W, Li H, Sun H, Shi B, Zhang Y.
Cai Y, et al.
Orphanet J Rare Dis. 2018 Mar 27;13(1):43. doi: 10.1186/s13023-018-0781-y.
Orphanet J Rare Dis. 2018.
PMID: 29587809
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite